These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17534145)

  • 1. In vitro efficacy of immuno-chemotherapy with anti-EGFR human Fab-Taxol conjugate on A431 epidermoid carcinoma cells.
    Wang X; Zhu J; Zhao P; Jiao Y; Xu N; Grabinski T; Liu C; Miranti CK; Fu T; Cao BB
    Cancer Biol Ther; 2007 Jun; 6(6):980-7. PubMed ID: 17534145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of a human anti-epidermal growth factor receptor Fab antibody, EG-19-11, with subnanomolar affinity from naïve immunoglobulin repertoires using a hierarchical antibody library system.
    Hur BU; Yoon JB; Liu LK; Cha SH
    Immunol Lett; 2010 Nov; 134(1):55-61. PubMed ID: 20797408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
    Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
    Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor (EGFR) density may not be the only determinant for the efficacy of EGFR-targeted photoimmunotherapy in human head and neck cancer cell lines.
    Peng W; de Bruijn HS; Farrell E; Sioud M; Mashayekhi V; Oliveira S; van Dam GM; Roodenburg JLN; Witjes MJH; Robinson DJ
    Lasers Surg Med; 2018 Jul; 50(5):513-522. PubMed ID: 29777587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor efficacy of an anti-epidermal-growth-factor-receptor monoclonal antibody and its F(ab')2 fragment against high- and low-EGFR-expressing carcinomas in nude mice.
    Tosi E; Valota O; Negri DR; Adobati E; Mazzoni A; Meazza R; Ferrini S; Colnaghi MI; Canevari S
    Int J Cancer; 1995 Sep; 62(5):643-50. PubMed ID: 7665239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oridonin inhibited the tyrosine kinase activity and induced apoptosis in human epidermoid carcinoma A431 cells.
    Li D; Wu LJ; Tashiro S; Onodera S; Ikejima T
    Biol Pharm Bull; 2007 Feb; 30(2):254-60. PubMed ID: 17268061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amlodipine, a Ca2+ channel blocker, suppresses phosphorylation of epidermal growth factor receptor in human epidermoid carcinoma A431 cells.
    Yoshida J; Ishibashi T; Yang M; Nishio M
    Life Sci; 2010 Jan; 86(3-4):124-32. PubMed ID: 19951711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2-mediated internalization of a targeted prodrug cytotoxic conjugate is dependent on the valency of the targeting ligand.
    Guillemard V; Nedev HN; Berezov A; Murali R; Saragovi HU
    DNA Cell Biol; 2005 Jun; 24(6):350-8. PubMed ID: 15941387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the in vitro function and internalization ability of a humanized EGFR antibody AE01 expressed by Chinese hamster ovary cells.
    Wu H; Ding X; Chen Y; Cai Y; Yang Z; Xu Q; Jin J
    Protein Expr Purif; 2023 Jun; 206():106243. PubMed ID: 36754125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role and mechanism of the regulation of nuclear factor-κB by heparin binding-epidermal growth factor-like growth factor in the induction of paclitaxel resistance of ovarian cancer].
    Tang XH; Lu MS; Deng S; Li M
    Zhonghua Fu Chan Ke Za Zhi; 2019 Apr; 54(4):255-261. PubMed ID: 31006192
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro and in vivo assessment of targeting lipid-based nanoparticles to the epidermal growth factor-receptor (EGFR) using a novel Heptameric ZEGFR domain.
    Benhabbour SR; Luft JC; Kim D; Jain A; Wadhwa S; Parrott MC; Liu R; DeSimone JM; Mumper RJ
    J Control Release; 2012 Feb; 158(1):63-71. PubMed ID: 22037106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of specific internalization Fab fragment from human naive phage library by combinational bio-panning.
    Wang X; Cao BB
    Methods Mol Biol; 2009; 525():161-74, xv. PubMed ID: 19252831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells.
    Mamot C; Ritschard R; Küng W; Park JW; Herrmann R; Rochlitz CF
    J Drug Target; 2006 May; 14(4):215-23. PubMed ID: 16777680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reverse of the resistance to paclitaxel of the heparin binding-epidermal growth factor-like growth factor inhibitor in ovarian cancer].
    Tang XH; Lu MS; Deng S; Li M
    Zhonghua Fu Chan Ke Za Zhi; 2017 Feb; 52(2):110-115. PubMed ID: 28253574
    [No Abstract]   [Full Text] [Related]  

  • 16. EGFR-targeting, β-defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosis.
    Liu WJ; Liu XJ; Xu J; Li L; Li Y; Zhang SH; Wang JL; Miao QF; Zhen YS
    Acta Pharmacol Sin; 2018 Nov; 39(11):1777-1786. PubMed ID: 30013033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial production and structure-functional validation of a recombinant antigen-binding fragment (Fab) of an anti-cancer therapeutic antibody targeting epidermal growth factor receptor.
    Kim JH; Sim DW; Park D; Jung TG; Lee S; Oh T; Ha JR; Seok SH; Seo MD; Kang HC; Kim YP; Won HS
    Appl Microbiol Biotechnol; 2016 Dec; 100(24):10521-10529. PubMed ID: 27470143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A collagen-binding EGFR antibody fragment targeting tumors with a collagen-rich extracellular matrix.
    Liang H; Li X; Wang B; Chen B; Zhao Y; Sun J; Zhuang Y; Shi J; Shen H; Zhang Z; Dai J
    Sci Rep; 2016 Feb; 6():18205. PubMed ID: 26883295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bispecific fusion protein and a bifunctional enediyne-energized fusion protein consisting of TRAIL, EGFR peptide ligand, and apoprotein of lidamycin against EGFR and DR4/5 show potent antitumor activity.
    Zhu D; Wang X; Shang Y; Li Y; Jiang W; Li L; Chen SZ
    Anticancer Drugs; 2015 Jan; 26(1):64-73. PubMed ID: 25122444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular imaging application of radioiodinated anti-EGFR human Fab to EGFR-overexpressing tumor xenografts.
    Xu N; Cai G; Ye W; Wang X; Li Y; Zhao P; Zhang A; Zhang R; Cao B
    Anticancer Res; 2009 Oct; 29(10):4005-11. PubMed ID: 19846943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.